Premium
Adjuvant Treatment Using Bleomycin in Squamous Cell Carcinoma of Penis: Study of 19 Cases
Author(s) -
MAICHE A. G.
Publication year - 1983
Publication title -
british journal of urology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.773
H-Index - 148
eISSN - 1464-410X
pISSN - 0007-1331
DOI - 10.1111/j.1464-410x.1983.tb03366.x
Subject(s) - bleomycin , methotrexate , penis , medicine , basal cell , vincristine , chemotherapy , adjuvant , oncology , surgery , cyclophosphamide , dermatology
Summary— Nineteen patients with squamous cell carcinoma of the penis had surgical treatment or a combination of surgery and radiation. They also had chemotherapy using bleomycin as a single agent or in combination with vincristine and methotrexate. The total doses of bleomycin varied between 89 mg/m 2 and 212 mg/m 2 . The best results were obtained in well differentiated carcinomas.